American Society of Clinical Oncology

SHERPA: White

People

  1. Voss
    Voss
  2. Motzer
    Motzer
  3. Feldman
    Feldman
  4. Carlo
    Carlo
  5. Chaim
    Chaim
  6. Knezevic
    Knezevic
  7. Kotecha
    Kotecha
  8. Aggen
    Aggen
  9. Duzgol
    Duzgol
  10. Shah
    Shah

Groups

  1. Body Imaging Service (17)
  2. Department of Medicine (17)
  3. Genitourinary Oncology Service (17)
  4. Radiology, Department of (17)
  5. Solid Tumor Oncology Division (17)
  6. Epidemiology and Biostatistics (12)
  7. Population Sciences Research Program (11)
  8. Biostatistics Service (9)
  9. Hematologic Malignancies, Division of (8)
  10. Molecular Imaging and Therapy Service (6)
Search Within
  1. "Martin Voss"
  2. "Body Imaging Service"
Formats
  1. Meeting Abstract (15)
  2. Journal Article (2)
Groups
  1. Body Imaging Service (17)
  2. Department of Medicine (17)
  3. Genitourinary Oncology Service (17)
  4. Radiology, Department of (17)
  5. Solid Tumor Oncology Division (17)
  6. Epidemiology and Biostatistics (12)

More Groups

People
  1. Martin Voss (17)
  2. Robert Motzer (16)
  3. Darren Feldman (15)
  4. Chung-Han Lee (14)
  5. Maria Carlo (11)
  6. Joshua Chaim (8)

More People

Years
  1. 2023 (3)
  2. 2022 (2)
  3. 2021 (1)
  4. 2020 (1)
  5. 2019 (4)
  6. 2018 (1)

More Years

Publications
  1. Journal of Clinical Oncology (17)

Results (17)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Associations of diet with survival of patients (pts) with metastatic cancer of the urothelium (mUC) and renal cell carcinoma (mRCC) on immune checkpoint blockade (ICB)
    Meeting Abstract

    Guercio, B. J.; Ratna, N.; Gavrilov, D.; Duzgol, C.; Akhlaq, M.; Teo, M. Y.; Regazzi, A. M.; Kotecha, R. R.; Funt, S. A.; Aggen, D. H.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Nivolumab plus cabozantinib in patients with non-clear cell renal cell carcinoma: Updated results from a phase 2 trial
    Meeting Abstract

    Lee, C. H.; Fitzgerald, K. N.; Voss, M. H.; Carlo, M. I.; Knezevic, A.; Peralta, L.; Chen, Y. B.; Zucker, M.; Lefkowitz, R. A.; Reznik, E.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Impact of sarcomatoid features on treatment outcomes in metastatic clear cell renal cell carcinoma treated with first-line immunotherapy combinations
    Meeting Abstract

    Fitzgerald, K. N.; Duzgol, C.; Knezevic, A.; Shapnik, N.; Kotecha, R. R.; Aggen, D. H.; Carlo, M. I.; Shah, N. J.; Voss, M. H.; Feldman, D. R.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Progression-free survival after second line of therapy (PFS-2) for metastatic clear cell renal cell carcinoma (ccRCC) in patients treated with first-line immunotherapy combinations
    Meeting Abstract

    Fitzgerald, K. N.; Duzgol, C.; Knezevic, A.; Shapnik, N.; Kotecha, R.; Aggen, D. H.; Carlo, M. I.; Shah, N. J.; Voss, M. H.; Feldman, D. R.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Phase II trial of cabozantinib plus nivolumab in patients with non-clear-cell renal cell carcinoma and genomic correlates
    Journal Article

    Lee, C. H.; Voss, M. H.; Carlo, M. I.; Chen, Y. B.; Zucker, M.; Knezevic, A.; Lefkowitz, R. A.; Shapnik, N.; Dadoun, C.; Reznik, E.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Nivolumab plus cabozantinib in patients with non-clear cell renal cell carcinoma: Results of a phase 2 trial
    Meeting Abstract

    Lee, C. H.; Voss, M. H.; Carlo, M. I.; Chen, Y. B.; Reznik, E.; Knezevic, A.; Lefkowitz, R. A.; Shapnik, N.; Tassone, D.; Dadoun, C.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • The spinal distribution of metastatic renal cell carcinoma: Support for locoregional rather than arterial hematogenous mode of early bony dissemination
    Meeting Abstract

    Attalla, K.; Duzgol, C.; McLaughlin, L.; Flynn, J.; Ostrovnaya, I.; DiNatale, R. G.; Silagy, A. W.; Coleman, J.; Lee, C. H.; Carlo, M. I.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Association of body mass index (BMI) with clinical outcomes in 203 metastatic clear cell renal cell carcinoma (ccRCC) patients (pts) treated with immuno-oncology (IO) agents
    Meeting Abstract

    Ged, Y.; Lee, C. H.; Sanchez, A.; Duzgol, C.; Chaim, J.; Carlo, M. I.; Foster, A.; Akin, O.; Feldman, D. R.; Hakimi, A. A.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Systemic therapy for advanced clear cell renal cell carcinoma (ccRCC) after progression on immune-oncology plus VEGF targeted therapy combinations (IO-VEGF)
    Meeting Abstract

    Ged, Y.; Gupta, R.; Duzgol, C.; Shapnik, N.; Redzematovic, A.; Kotecha, R.; Voss, M. H.; Feldman, D. R.; Akin, O.; Patil, S.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Outcomes of patients with metastatic clear cell renal cell carcinoma treated with second-line VEGFR-TKI after first-line immune checkpoint inhibitors
    Meeting Abstract

    Shah, A. Y.; Kotecha, R.; Lemke, E.; Chandramohan, A.; Chaim, J.; Msaouel, P.; Xiao, L.; Gao, J.; Campbell, M. T.; Zurita, A. J.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save